NCT06051136

Brief Summary

In Italy, the incidence of lung cancer for the year 2020 has been estimated at about 41.000 new diagnoses. Patients with lung cancer experience debilitating symptoms caused by the disease itself and cancer treatments, such as dyspnea and fatigue, which reduce physical function and quality of life (QoL). It is estimated that 90% of patients undergoing chemotherapy and 57% of patients undergoing lung resection suffer of Cancer-Related Fatigue (CRF). Previous studies have shown that educational interventions and aerobic and resistance exercise are effective in improving CRF and QoL in patients with lung cancer. However, to date the optimal dose, mode and timing to deliver the intervention during the care pathway for lung cancer patients is unknown. Tolerability and frequency of cancer treatment could be a barrier to adherence to the intervention. Therefore, this study aims to evaluate the feasibility of a rehabilitation intervention aimed at improving CRF with respect to timing of delivery: early vs delayed rehabilitation in lung cancer patients.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable lung-cancer

Timeline
Completed

Started Feb 2023

Typical duration for not_applicable lung-cancer

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 28, 2023

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

September 17, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 22, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2024

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

April 2, 2025

Status Verified

March 1, 2025

Enrollment Period

1.8 years

First QC Date

September 17, 2023

Last Update Submit

March 27, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Feasibility - Adherence rate to the outpatient RP sessions

    The number of patients adhering to at least 70% of outpatient RP sessions scheduled for the relative allocation group will be recorded.

    At 3 and 6 months after baseline

Secondary Outcomes (9)

  • Recruitment rate

    At baseline

  • Dropout rate

    At 3 and 6 months after baseline

  • Cancer-related fatigue (CRF)

    At baseline, at 3, 6, and 12 months after baseline

  • Quality of life (QoL)

    At baseline, at 3, 6, and 12 months after baseline

  • Physical performance

    At baseline, at 3 and 6 months after baseline

  • +4 more secondary outcomes

Study Arms (2)

Early pulmonary rehabilitation (RP)

EXPERIMENTAL

RP immediately after enrollment.

Behavioral: Pulmonary rehabilitation

Delayed pulmonary rehabilitation (RP)

EXPERIMENTAL

RP after 3 months after enrollment.

Behavioral: Pulmonary rehabilitation

Interventions

The RP intervention consists in 8 sessions supervised by the physiotherapist weekly or biweekly and 2 therapeutic education group meetings on the importance of exercise and CRF management, over the 3 months of intervention. The RP comprise exercise program performed autonomously at home. Both the outpatient and the autonomously home-based exercise sessions comprise aerobic, resistance and respiratory exercise. The exercise program is individualized and can be delivered in telerehabilitation.

Delayed pulmonary rehabilitation (RP)Early pulmonary rehabilitation (RP)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Newly diagnosed of stage II and III lung cancer (NSCLC) candidates for anticancer therapies (chemotherapy, radiotherapy, immunotherapy, or combinations thereof), associated or not with surgery. In the last case, patients will be included at least 30 days after surgery.
  • Prognosis ≥ 12 months
  • At least 18 years old
  • Recruited from the pneumology, oncology, radiotherapy, and physical medicine and rehabilitation unit of the Azienda Unità Sanitaria Locale - IRCCS of Reggio Emilia
  • Willing and able to give written informed consent

You may not qualify if:

  • Clinical disorders that contraindicate participation in a moderate exercise program (e.g. preexisting severe physical disabilities, major cognitive or sensory deficits, severe psychiatric disorders, language barrier, etc.).
  • NSCLC stage IV
  • Patients who are candidates for surgery alone
  • Patients who are candidates for neoadjuvant therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia

Reggio Emilia, Reggio Emilia, 42123, Italy

Location

Related Publications (1)

  • Fugazzaro S, Mainini C, Pecorari A, Denti M, Galavotti MB, Messori M, Costi S, Ciammella P, Falco F, Zanelli F, Cavuto S, Bressi B. Feasibility of an early versus delayed rehabilitation intervention in patients with lung cancer on cancer-related fatigue: a pilot RCT. Future Oncol. 2026 Jan 6:1-10. doi: 10.1080/14796694.2025.2607632. Online ahead of print.

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Stefania Fugazzaro, Dr.

    Azienda USL Reggio Emilia - IRCCS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The randomization will be done online directly from Smarty, the software that will manage the eCRF for collecting of the study data. Furthermore, outcomes will be assessed blindly by staff involved in the research project who do not directly deliver the intervention.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Single-center, two-arm, open-label pilot RCT.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 17, 2023

First Posted

September 22, 2023

Study Start

February 28, 2023

Primary Completion

December 12, 2024

Study Completion

December 31, 2025

Last Updated

April 2, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations